| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55566 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-107 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-095 |
| filingDate |
2015-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ee3dbfd8fc8d18bb9a7aaaec66bd9bb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_94c5d2abf422906eaa2f44b0444f72bf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bbc58f5d8f60849e5bffd4a80f827a07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_05084886250253fcbc765bb9d39e60e9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b2b984447a9d94d7c3264ecba76fff61 |
| publicationDate |
2016-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2016029108-A |
| titleOfInvention |
Meningococcal vaccine formulation |
| abstract |
A meningococcal vaccine formulation is provided. A two-component formulation for a vaccine against Neisseria meningitidis serogroup B (“Men-B”) comprises (i) an oil-in-water emulsion adjuvant and (ii) a lyophilized form of Men-B immunogenicity. And ingredients. The lyophilized Men-B antigen can be reconstituted into a liquid adjuvanted form at the time of use for administration to a patient. This formulation has been found to give excellent results with respect to both stability and immunogenicity. The lyophilized component may further comprise a serogroup A, C, W135, and / or Y.N. One or more complex sugars derived from meningitidis may also be included. [Selection] Figure 1 |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2021501144-A |
| priorityDate |
2007-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |